Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7657
|
pubmed:dateCreated |
1970-7-1
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1130-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:4192093-Age Factors,
pubmed-meshheading:4192093-Aged,
pubmed-meshheading:4192093-Amantadine,
pubmed-meshheading:4192093-Female,
pubmed-meshheading:4192093-Humans,
pubmed-meshheading:4192093-Male,
pubmed-meshheading:4192093-Middle Aged,
pubmed-meshheading:4192093-Parkinson Disease,
pubmed-meshheading:4192093-Sex Factors
|
pubmed:year |
1970
|
pubmed:articleTitle |
Amantadine dosage in treatment of Parkinson's disease.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|